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Abstract
Diabetes prevalence is on the rise in the UK, and for public health strategy, estimation
of relative disease risk and subsequent mapping is important. We consider an application
to London data on diabetes prevalence and mortality. In order to improve the estimation of
relative risks we analyse jointly prevalence and mortality data to ensure borrowing strength
over the two outcomes. The available data involves two spatial frameworks, areas (middle
level super output areas, MSOAs), and general practices (GPs) recruiting patients from
several areas. This raises a spatial misalignment issue that we deal with by employing
the multiple membership principle. Specifically we translate areal spatial effects to explain
GP practice prevalence according to proportions of GP populations resident in different
areas. A sparse implementation in RStan of both the MCAR and GMCAR with multiple
membership allows the comparison of these bivariate priors as well as exploring the different
implications for the mapping patterns for both outcomes. The necessary causal precedence
of diabetes prevalence over mortality allows a specific conditionality assumption in the
GMCAR, not always present in the context of disease mapping. Additionally, an area-
locality comparison is considered to locate high vs low relative risk clusters.
1 Introduction and motivating example
When dealing with socio-economic or health data it is common for individuals to be classified
according to nested hierarchical structures. When it is necessary to account for level specific
effects, hierarchical models are better suited than standard regression techniques (Fielding et al.,
2006). However, the most common setup of such models requires lower level units to belong to
only one class in the hierarchy. When this perfect nesting is absent, as in cross classification (e.g.
students classified by area of residence and school) an alternative modelling strategy is needed.
Issues of multiple membership may then occur under one (or more) crossed categories (Fielding
et al., 2006). As an educational example, this structure can occur for pupils who attended more
than one school during their educational career; when modelling random effects for a particular
outcome, it might be useful to account for the different impacts that different schools might have
had on the individual student outcome. This is where multiple membership (MM) strategies
become an alternative to a classical hierarchical model: by choosing appropriate weights and
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averaging the random effects, e.g. over different schools attended, it is possible to account for
the different memberships of a specific unit at a certain level (Browne et al., 2001). A mixed
structure is also exemplified by patients that are classified by both their area of residence and
the medical general practitioner (GP) primary care practice they are registered at.
In this paper, the main problem under consideration is to jointly estimate relative risk of
diabetes mortality and prevalence where data for the former comes from census Middle Layer
Super Output Areas (MSOA), while the latter is collected for GP disease registers. Generally, in
the context of areal disease mapping it is common to model outcomes (e.g. mortality, prevalence)
with a generalized linear model (GLM) (Lawson, 2018) using area counts as observations and
conditional autoregressive priors (CAR, Besag et al., 1991) to account for spatially structured
residuals. Additionally, expected disease counts or disease prevalence would be included as
offsets in the model, to account for different population structures among the areas. Also
included are known risk factors as covariates. This method can be applied to two areal outcomes
leading to a bivariate model. However, this modelling strategy is based on the two outcomes
sharing the same areal framework. This is not the case in the application here, since residents of
a specific MSOA can be registered at a GP practice outside it, making it impossible to attribute
all the patients of a practice to the area it is in.
The data framework used here comprises 130 GP practices in three Clinical Commissioning
Groups (CCGs) in outer northern east London (ONEL). MSOAs were included (in ONEL and
beyond) if their residents were among the largest contributors to the selected GP populations.
This procedure results in 95 MSOAs, 88 of which are actually in ONEL. With this data we
aim to analyse prevalence and mortality risk for MSOAs using prevalence information for GP
practices.
To the best of the authors’ knowledge, there are no previous Bayesian studies of the spatial
causal relationship between diabetes prevalence and mortality. One aim of the study is to
examine the strength of this relationship (if any) at a small area scale. This relationship is
attenuated at individual patient level because diabetes as a disease can be followed by cause
by death from many other conditions, thus making more difficult to list it as cause of death.
Consequently, McEwen et al. (2006) reports that of nearly 12,000 diabetic patients in the US,
diabetes was recorded on a minority (39%) of death certificates, and as the underlying cause of
death for only 10% of decedents with diabetes. There is also the issue of accurate recording:
many studies report that diabetes is an underreported cause of death. Stokes et al. (2017)
report that the proportion of deaths with diabetes assigned as the underlying cause of death
(3.3–3.7%) severely understates the contribution of diabetes to mortality in the United States.
Dealing with multiple membership in this example is an illustration of spatial misalignment
(Banerjee et al., 2014). In order to deal with the misalignment problem present in the study here,
our approach involves multiple membership (MM) modelling of prevalence data, making MSOA
spatial random effects for prevalence indirectly identified by GP prevalence data. Additionally,
since causal precedence is evident given that prevalence necessarily precedes mortality, a specific
modelling approach will then be evaluated, namely the GMCAR from Jin et al. (2005), in order
to embed the causal information in the estimation process.
Therefore, the main contribution of this paper is methodological: the incorporation of the
multiple membership approach into a spatial prior. Previous applications of multiple mem-
bership have been in crossed multilevel applications (e.g. educational careers for pupils within
schools) with unstructured priors. Another significant contribution is computational, as to the
best of our knowledge this is the first implementation of a bivariate CAR spatial prior into Rstan
(Carpenter et al., 2017; Stan Development Team, 2018), a probabilistic programming platform
which performs full Bayesian inference using Hamiltonian Monte Carlo (HMC). Previous Rstan
implementations or CAR priors have been univariate (Morris et al., 2019; Joseph, 2016). Lastly,
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there is novelty in the application of the methods to the specific disease studied, and in showing
how spatial priors can be applied to distinct health outcomes (e.g. prevalence, mortality) where
causal precedence is clear.
The paper is organised as follows. We briefly describe the motivating dataset in Section
1.1. In Section 2 we review conditional autoregressive priors for modelling bivariate area disease
counts and in Section 3 we incorporate the multiple membership approach into a spatial prior.
We discuss the implementation of this approach in Stan in Section 3.1. A simulation study is
included in Section 4 and findings regarding the motivating dataset on diabetes prevalence and
mortality are presented in Section 5.
1.1 Data structure
Data on diabetes mortality is available from Census units called Middle Layer Super Output
Areas (MSOAs), while data on diabetes prevalence is available for GP disease registers. With
this data we aim to analyse prevalence and mortality risk for MSOAs using prevalence inform-
ation for GP practices.
The data framework comprises all 130 GP practices in three Clinical Commissioning Groups
(CCGs) in outer northern east London (ONEL): Barking and Dagenham, Havering and Red-
bridge. MSOAs were included if their residents were among the largest contributors to the
selected GPs populations up to the 90th percentile. This procedure results in 95 MSOAs, 88 of
which are actually in ONEL.
The misalignment must be modelled carefully as it is significant: on average 43.4 MSOAs
contribute to the population of each GP (median 41 and range 14 to 80), and the average
contribution of each MSOA to the population of a single GP is 2.3% (median 0.19 %) ranging
between 0.0059% to 96 % (see Figure 1 as an example of a population catchment area for a GP
practice).
Mortality data by MSOA include death counts from 2013 to 2017. Consequently October
2015 was chosen as midpoint for retrieving prevalence data, and also for residential patient flow
data for each GP; the latter provides a cross reference file linking MSOA and GP populations.
In addition to that, two covariates recorded at the MSOA level have been included, namely the
proportion of South Asian residents from the 2011 Census 1 and the 2015 Index of Multiple
Deprivation (IMD). The former variable has been included due to the higher prevalence of
diabetes among the South Asian population (Hall et al., 2010), while the latter is a control
variable for area socio-economic status.
For the purpose of estimating areal prevalence and mortality, it is necessary to take into ac-
count population structure, therefore expected counts for each area are computed using national
rates for mortality and prevalence, together with the number of residents by age. This gives
Eik =
A∑
a=1
ωakN
a
ik (1)
where i = 1, ..., n is the area, k = 1, ...,K the outcome, a = 1, . . . , A is the population age group,
ωak are the national mortality and prevalence rates for diabetes broken down by age group
together with Naik the corresponding MSOA or GP populations (Blangiardo et al., 2015). In the
case of prevalence offset computation, index i for MSOAs must be substituted by j = 1, ...,m
indexing GPs instead.
1Which include the following ethnicities: Indian, Pakistani and Bangladeshi, taken from Table KS201EW in
the NOMIS database
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Figure 1: Example of contributing MSOAs populations for a specific GP practice, identified by
a black dot on the map.
2 Modelling and conditional autoregressive priors (CAR)
Generalised linear models (GLM) with spatially correlated random effects are commonly used
in spatial data analysis. We consider a spatial GLM with Gaussian CAR random effects where
a region is partitioned in n non-overlapping areas. For each area i = 1, . . . , n we can observe
a random variable representing the outcome of interest Yi and a set of p non-random covari-
ates xi = (xi1, . . . , xip). Define Ei as known offset values, and ρi as the relative disease risk
(Blangiardo et al., 2015).
The methods in this paper apply to all GLMs but, without loss of generality, in this paper
we will model count data using the Negative Binomial distribution with mean µi for each ob-
servation, a common overdispersion parameter ψ and a logarithmic link function. The Negative
Binomial allows explicit modelling of overdispersion, when the variance in the outcome is larger
than the average outcome (Coly et al., 2019).
We can then write the GLM with the CAR term φi, defined below, as:
Yi ∼ NegBin(Eiρi, ψ)
log(ρi) = γ + xiβ + φi
(2)
To model explicitly the overdispersion, we set µi = Eiρi so it follows that
fY (yi;µi, ψ) =
(
yi + ψ − 1
yi
)(
µi
µi + ψ
)yi ( ψ
µi + ψ
)ψ
∀i = 1, . . . , n (3)
where y ∈ R+; E(Yi) = µi ∈ R+, ψ ∈ R+ and V ar(Yi) = µi + µ2i /ψ.
4
The set of areal units on which data are recorded can form a regular lattice or differ largely
in both shape and size. In either case such data typically exhibit spatial autocorrelation, with
observations from areal units close together tending to have similar values. By assuming a
Gaussian Markov random Field (GMRF) on the lattice (Rue et al., 2005) it is possible to define
φi through the following full conditionals,
φi|φ−i ∼ N(α
∑
∂i
bijφj , τ
−1
i ) (4)
where ni is the number of neighbours for area i, bij is an element of matrix B defined below,
τ−1i = (τ/ni)
−1 and α, a propriety parameter, is usually interpreted as a smoothing parameter.
Thanks to Brook’s Lemma (Rue et al., 2005) it is guaranteed that the joint distribution is
proper, and it is given by
φ ∼ Nn(0, [τD(I − αB)]−1)
where 0 < α < 1
(5)
where B = D−1W , D = diag(mi) with mi is the number of neighbours for area i and W is
the adjacency matrix such that (W )ii = 0 and (W )ij = 1 if i and j are neighbours. This setup
can give rise to different prior choices that require different conditions to achieve properness
(Congdon, 2014).
Building from Mardia (1988) we can specify a K -dimensional multivariate spatial model.
However, general conditions for positive definiteness and invertibility for the covariance matrix
are difficult to assess. Therefore, we use the following formulation by Gelfand et al. (2003)
v ∼ NnK (0, [(D − αW )⊗ Λ])−1 (6)
where Λ is a K × K matrix that controls the variance and covariance between outcomes in
the same area, and is therefore required to be symmetric positive definite. This model will be
denoted as MCAR(α,Λ). An MCAR prior for spatial random effects allows estimates of relative
risks to borrow strength from each other. This is a reasonable assumption for our motivating
example, as diabetes prevalence and mortality are correlated. The MCAR on spatial effects can
capture such relationship and improve the estimate for both outcomes.
When considering prevalence and mortality for the same disease, given the necessary preced-
ence of prevalence on mortality, it is possible to draw a causal link between the two outcomes. In
order to embed that information in the model we can use the GMCAR (Jin et al., 2005), a spe-
cification of the previously mentioned MCAR for the bivariate case, that is based on estimating
the spatial effects for one outcome conditionally on the other, as follows.
φ1|φ2 ∼ Nn((η0In +Wη1)φ2, [τ1(D − α1W )]−1)
φ2 ∼ Nn(0, [τ2(D − α2W )]−1)
with |α1| < 1 and |α2| < 1
(7)
In our context, φ1|φ2 would be the spatial random effect for mortality given the spatial structure
of prevalence, while φ2 would be the spatial structure for prevalence. In (7) the parameter α1 is
the smoothing parameter associated with the conditional distribution of φ1|φ2, α2 is similarly
defined for the marginal distribution of φ2, and τ1 and τ2 scale the precision of φ1|φ2 and φ2,
respectively. As the conditional expected value is linear in η0 and η1, these two parameters
reflect the linear relationship between the two diseases risks. The parameter η0 represents
area specific (own area) spatial dependence, while η1 refers to the neighbour effect between
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the two outcomes. We will refer to this model as GMCAR(α1, α2, η0, η1, τ1, τ2). A particularly
interesting feature of model (7) is that for the bivariate case by setting η1 = 0 and α1 = α2 we
obtain the MCAR(α,Λ) of equation (6).
Finally, in Section 3, Jin et al. (2005) show how to generalise the GMCAR model to K
outcomes, by defining conditional distributions sequentially. In the present context, one might
take obesity as preceding both diabetes prevalence and mortality. For K = 3 the joint density
of the random effects can be written as:
p(φ) = p(φ1 | φ2,φ3)p(φ2 | φ3)p(φ3) (8)
with φT = (φT1 ,φ
T
2 ,φ
T
3 ) and properness trivially satisfied.
3 Multiple membership for areal misalignment
In this paper we leverage the MM principle (Browne et al., 2001) by building memberships with
averages of areal relative risks. Let Yk = (Y1k, ..., Ymkk) be the vector of observed counts for
outcome k = 1, ...,K with mk memberships. We will define the relative risk of each membership
of Yk by a weighted average of areal relative risks. Indicating areas with i = 1, ..., n, we can
specify a set of weights for each membership j = 1, ...,mk as:
wi|j,k s.t.
n∑
i=1
wi|j,k = 1 (9)
where obviously wi|j,k = 0 for the areas i that do not contribute to membership j.
Referring back to Equation 2, where we introduced areal relative risk for area i, the new
specification for membership k will be:
Yjk ∼ NegBin(Ejkρjk, ψk)
log(ρjk) =
n∑
i=1
wi|j,k(γk + xikβk + φik)
(10)
where Ejk are as in Equation 1.
Given appropriate weights and memberships, this setup can be extended to an indefinite
number of outcomes. However, in the present analysis we limit ourselves to two outcomes, and we
apply the scheme to deal with the misalignment arising from the discrepancy in the way mortality
and prevalence data are collected. Firstly, patients from different and non neighbouring MSOAs
can register at the same GP (i.e. the mapping from MSOAs to GPs is not injective) and,
secondly, individuals from the same MSOA can register at different GPs.
We obtain practice specific weights based on the relative contribution of each MSOA (in
terms of population affiliated) to each practice. In the dataset we include non-zero weights only
for the MSOAs with the largest contributions, namely those constituting up to 90% coverage of
the GP practice population.
For each practice different MSOAs contribute with a different weight, so the idea is that the
prevalence relative risk for each GP is then computed as an average of MSOA level risks. We
can safely drop the second subscript k for wi|j,k from Equation 9, since we have only one MM
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outcome. Specifying the model from Equations 2 and 10
MSOAs : i = 1, . . . , n (11)
GPs : j = 1, . . . ,m (12)
yi1 ∼ NegBin(Ei1ρi1, ψ1) (13)
yj2 ∼ NegBin(Ej2ρj2, ψ2) (14)
log(ρi1) = γ1 + xiβ1 + φi1 (15)
log(ρj2) =
n∑
i=1
wi|j(γ2 + xiβ2 + φi2) (16)
where the spatial random effects are modelled as either
φ1,φ2 ∼ GMCAR(α1, α2, η0, η1, τ1, τ2) (17)
or
φ1,φ2 ∼ MCAR(α,Λ). (18)
and priors are defined for parameters β, α1, α2, γ1, γ2, η0, η1, τ1, τ2, ψ1, ψ2. The covariates coef-
ficients βj = (βj1, . . . , βjP ) with j = 1, 2 indexing the outcome (1 for mortality and 2 for
prevalence), wi|j each area’s MM weight, and p = 1, . . . , P the covariate. We refer to this model
as either GMCAR-MM or MCAR-MM, depending on whether the GMCAR or MCAR prior is
used.
Since we are mostly interested in relative risk by area rather than membership, we introduce
the following notational shortcut to denote the estimated areal component for outcomes observed
by membership. We then refer to Equation 10 as:
n∑
i=1
(γk + xikβk + φik) =
n∑
i=1
wi|jζik (19)
so that ζik = γk +xikβk +φik indicates the relative risk for area i implicitly defined by multiple
membership.
3.1 Implementation
To the best of our knowledge, this is the first implementation of multivariate CAR models
(GMCAR and MCAR) in RStan (Carpenter et al., 2017). The code is available on github at
https://github.com/silvialiverani/GMCARMM.
Since the MCAR prior can be viewed as a special case of the GMCAR (see Section 2),
the latter was coded first, while the implementation of the former was achieved by adding the
necessary constraints, i.e. η1 = 0 and α1 = α2.
We implemented a QR parameterisation (section 1.2 of Stan Development Team (2018))
for the estimation of the parameters β, which exploits the fact that any design matrix X can
be decomposed using the thin QR decomposition into an orthogonal matrix Q and an upper-
triangular matrix R, i.e. X = QR. This parameterisation performs much better in practice,
often both in terms of elapsed time and in terms of effective sample size, as it makes it easier for
the Monte Carlo algorithm to move in the space when an informative prior on the location of β
is not available. Moreover, before obtaining the QR decomposition we have also implemented a
min-max normalisation of the covariates.
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Table 1: Prior distributions and hyperparameters. The Γ distribution parametrization is in
terms of shape and rate, and the Half-Normal in terms of σ2.
Rstan Priors
α1 ; α2 U(0, 1)
γ1; γ2; η0; η1; N(0, 25)
β Flat prior
τ1; τ2 Half-Normal(25)
ψ1; ψ2 Γ(1, 0.1)
R2OpenBUGS Priors
α1 ; α2 U(0, 1)
γ1; γ2; η0; η1; N(0, 25)
β N(0, 100)
τ1; τ2 Half-Normal(25)
ψ1; ψ2 Γ(1, 0.1)
Sampling for both covariance matrices of the CAR component was coded using unit precision,
i.e. setting τ1 = τ2 = 1 in equation (7), and rescaling the φ1 and φ2. Additionally, since
calculating the determinant for those covariance matrices would be extremely computationally
expensive, Joseph (2016) implemented an eigenvalue decomposition in Stan, as suggested by Jin
et al. (2005), reducing the computational burden significantly.
We used flat priors for the parameters β, while for the other parameters we used independent,
proper, weakly informative prior distributions, as recommended by Gelman, Carlin et al. (2013).
A list of the prior distributions is on the left hand side of Table 1.
Convergence was assessed with the Rˆ diagnostic (Gelman and Rubin, 1992), and accordingly
satisfactory convergence is achieved for values below 1.01 (Vehtari, Gelman, Simpson et al.,
2019).
3.2 Risk clustering
Following Congdon (2019) we will assess spatial clustering by comparing the average relative
risk over the HMC iterations for each area with both their neighbouring areas, or locality, and
the other outcome, thus measuring bivariate clustering.
An adaptation of LISA (Local Indicator of Spatial Association), proposed by Laohasiriwong
et al. (2017), will be used: firstly, we compute the probability of a certain area having an excess
relative risk with high probability. This is achieved by computing the percentage of the sampled
relative risks in the HMC chains over a certain threshold (usually taken as 1). Therefore, for
area i, outcome k and probability threshold TR we have, using the s = 1, ..., B HMC samples:
PH(i, k) =
1
B
B∑
s=1
I
(
ρ
(s)
ik > TR
)
(20)
where I(·) is the indicator function. The use of Monte Carlo iterations allows to account for
uncertainty in the risk assessment.
Secondly, once these quantities are obtained, corresponding probabilities for each of the
localities are computed as follows. Substituting relative risk for area i and iteration s with the
average relative risk of locality (ρ
(s)
∼ik), Equation (20) becomes:
PH(∼ i, k) = 1
B
B∑
s=1
I
(
ρ
(s)
∼ik > TR
)
(21)
where we define ρ
(s)
∼ik, using adjacency matrix W from Section 2:
ρ
(s)
∼ik =
1
mi
mi∑
j=1
(W )ijρ
(s)
jk (22)
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and mi =
∑n
j=1(W )ij is the number of areas in the locality i.
Finally, with both PH(i, k) and PH(∼ i, k) for each area, we can evaluate if area i is the
centre of a high or low risk cluster by comparing if both PH ’s are above threshold TP (usually
0.9 or 0.95). With this type of comparison, we are able to classify each area in one of 4 different
categories based on either PH(i, k) or PH(∼ i, k) being above TP . These four categories are
High-High (HH), High-Low (HL), Low-High (LH) and Low-Low (LL).
When an area’s risk is compared with the respective locality risk for each outcome separately,
we can obtain a bivariate classification of areas. Since we can obtain 4 categories for each
outcome, for bivariate clustering we will have 16, as shown in Table 13. However, in order to
simplify the interpretation of a map (see Figure 8), only four categories will be represented by
focusing on within area comparisons e.g. for an area with high relative risk for mortality and
low risk for prevalence we will write M:H-P:L.
3.3 Model comparison
To choose among competing models, we used the deviance information criterion, or DIC (Spiegel-
halter et al., 2002). This criterion is based on the posterior distribution of the deviance statistics.
For simplicity of notation, we will refer to the parameters of the Negative Binomial with the
vector θ = (µ1, . . . , µn, ψ) so we can write its saturated deviance as:
D(θ) = 2
n∑
i=1
yi log
(
yi
µi
)
− (yi + ψ) log
(
1 + yi/ψ
1 + µi/ψ
)
(23)
We compute both the average posterior deviance D(θ) and the deviance of averages of para-
meters’ posterior D(θ¯). For the former, when all aspects of the model are assumed true, the
approximation D(θ) ≈ n holds (Spiegelhalter et al., 2002), where n is the number of obser-
vations. Consequently, this can also be used as a measure of fit. Computing the posterior
deviances allows to easily compute also the effective number of parameters, pD = D(θ)−D(θ).
Moreover, lack of fit of the data with respect to the posterior predictive distribution can be
measured by the tail-area probability (TAP), or p-value, of the test quantity (Gelman, Carlin
et al., 2013). For each observation i = 1, . . . , n and each outcome we can estimate:
pi = P (y
rep
i < yi|y) +
1
2
P (yrepi = yi|y) (24)
where the yrepi are sampled at each HMC iteration from the likelihood conditional on the current
sampled parameters. The probabilities are estimated by the proportion of times the events
yrepi < yi or y
rep
i = yi occur throughout the chain. In case of an adequate model the pi’s are
expected to concentrate around 0.5 and away from the tails of the distribution, so by evaluating
the tails of the estimated TAP’s we can see how frequently the replicated values over (or under)
predict the observed ones. Specifically we consider the proportion of TAP’s that higher than
0.95 and lower than 0.05, as well as higher than 0.90 and lower than 0.1.
We also evaluate approximate leave-one-out cross-validation (LOO) (Vehtari, Gelman and
Gabry, 2017), comparing models (say A and B) by computing mean and standard error of the
difference in elpd :
se(êlpd
A
loo − êlpd
B
loo) =
√
nV ni=1(êlpd
A
loo,i − êlpd
B
loo,i) (25)
where V ni=1(x) is the sample variance, i.e. V
n
i=1(x) =
1
n−1
∑n
i=1(xi − x¯).
9
4 Simulation study
To validate our implementation we coded the GMCAR-MM and MCAR-MM models with mul-
tiple membership in BUGS and compared it with the Rstan runs. The BUGS (Bayesian infer-
ence Using Gibbs Sampling) project (Lunn et al., 2000) is concerned with flexible software for
the Bayesian analysis of complex statistical models using Markov chain Monte Carlo (MCMC)
methods. Although BUGS is a very popular software for Bayesian hierarchical modelling, it is
important to note that it is no longer maintained. We compared our Rstan implementation of
the models above to an implementation in R2OpenBUGS (Sturtz et al., 2005) (referred to as
BUGS henceforth). The priors used in the BUGS implementation are provided in Table 1
We generated four datasets: one with GMCAR-MM to simulate spatially varying effects with
covariates, one with GMCAR-MM to simulate spatially varying effects without covariates, one
with MCAR-MM to simulate spatially varying effects with covariates, one with MCAR-MM to
simulate spatially varying effects without covariates. We chose realistic parameter values in our
simulation, in line with the posterior means of the results on real data in Section 5, as well as
the true ONEL spatial lattice of 95 MSOAs, the offsets and true covariates mentioned in Section
1.1 to generate new observations for mortality and prevalence. Keeping these parameters fixed,
we simulated each dataset 100 times type and estimated the corresponding model using both
BUGS and RStan.
Direct implementation of the Negative Binomial, as parametrised in equation (3), is not
available in BUGS. Therefore we implemented it using the equivalent formulation via a Poisson-
Gamma mixture (Hilbe, 2011). Table 1 shows the priors and parameters for both implement-
ations. Both Half-Normal and QR reparametrization are not available in BUGS so for the
precision parameters τj we used weak Gamma priors and for covariates coefficients β very vague
Normal priors.
Tables 2, 3 and 4 show summaries of the distribution of the posterior means obtained across
the 400 simulated datasets (100 for each model). Each posterior was obtained by running 4
chains each with 50% warm-up and 6000 iterations for BUGS, while RStan required only 3000
iteration per chain to achieve convergence. Given the different number of iterations employed
for the two packages, computational times are lower for RStan since each run took on average
4’10” to complete against BUGS’s 9’20”. Simulations were run on Queen Mary’s Apocrita HPC
facility, supported by QMUL Research-IT (King et al., 2017).
The results show that RStan reports better convergence as the percentage of Rˆ below 1.1 or
even 1.01 are significantly lower than in the BUGS case. The 95% posterior credible intervals
generally contain the true values, both programs report similar results in this regard.
5 Analysis of diabetes data
As detailed in Section 1.1, we aim to analyse prevalence and mortality risk for MSOAs using
prevalence information for GP practices. The dataset comprises 130 GP practices, and the 95
MSOAs residents of which were among the largest contributors to the selected GPs populations.
To analyse the dataset we ran 4 chains each with 2500 iterations of HMC and 50% warm-
up using RStan. The models we considered are the GMCAR-MM and the MCAR-MM both
including and excluding covariates. Table 5 reports the posterior parameter estimates.
In Table 5 the model notation -C refers to models including covariates (MSOA South Asian
ethnicity and IMD deprivation index).
Tables 7 and 8 compare model fit using the DIC and LOO criteria. It can be seen that there
are relatively small differences on these criteria between comparable models (i.e. models with
covariates and models without covariates). The average posterior deviances are approximately
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Table 2: Summary descriptive statistics of posterior means for the parameters of interest in
the 100 simulations (models without covariates). BUGS (grey lines) and Rstan (white lines).
Results from running 4 chains, 6000 iterations for BUGS, 3000 for RStan and 50% warm-up for
both. %Rˆ > t indicates the percentage of Rˆ over threshold t in the 100 simulations
GMCAR-MM
True mean sd 2.5% 97.5% %Rˆ > 1.01 %Rˆ > 1.1
α1 0.40 0.50 0.03 0.45 0.56 0.00 0.00
α1 0.40 0.50 0.04 0.45 0.57 3.00 1.00
α2 0.90 0.65 0.15 0.39 0.91 44.00 0.00
α2 0.90 0.66 0.14 0.38 0.91 2.00 0.00
τ1 6.00 6.10 0.63 4.93 7.14 76.00 0.00
τ1 6.00 6.10 0.67 4.79 7.18 0.00 0.00
τ2 4.00 5.05 1.42 2.57 7.37 100.00 12.00
τ2 4.00 4.87 1.58 2.16 7.48 2.00 1.00
η0 0.30 0.50 0.35 -0.19 1.16 100.00 26.00
η0 0.30 0.48 0.33 -0.11 1.17 2.00 1.00
η1 0.50 0.57 0.17 0.32 0.90 100.00 22.00
η1 0.50 0.57 0.17 0.30 0.86 3.00 1.00
ψ1 20.00 21.19 3.61 14.64 27.50 39.00 0.00
ψ1 20.00 21.20 3.87 12.91 28.28 0.00 0.00
ψ2 10.00 10.00 1.11 7.96 12.21 7.00 0.00
ψ2 10.00 10.34 1.40 8.52 13.22 1.00 1.00
γ1 0.50 0.50 0.18 0.14 0.81 81.00 0.00
γ1 0.50 0.49 0.19 0.12 0.80 7.00 1.00
γ2 1.30 1.30 0.06 1.19 1.41 89.00 2.00
γ2 1.30 1.31 0.07 1.19 1.42 4.00 0.00
MCAR-MM
True mean sd 2.5% 97.5% %Rˆ > 1.01 %Rˆ > 1.1
α 0.40 0.43 0.09 0.30 0.66 11.00 0.00
α 0.40 0.42 0.08 0.31 0.56 0.00 0.00
τ1 6.00 6.15 0.71 4.52 7.37 74.00 0.00
τ1 6.00 6.09 0.73 4.85 7.59 0.00 0.00
τ2 4.00 5.50 1.23 3.11 7.42 86.00 2.00
τ2 4.00 5.70 1.41 2.84 7.83 0.00 0.00
η0 0.30 0.20 0.37 -0.49 0.87 99.00 12.00
η0 0.30 0.16 0.33 -0.54 0.73 0.00 0.00
ψ1 20.00 20.92 3.94 13.54 28.20 21.00 0.00
ψ1 20.00 20.49 3.96 12.01 27.82 0.00 0.00
ψ2 10.00 10.05 1.29 8.25 13.34 3.00 0.00
ψ2 10.00 9.99 1.44 7.70 13.19 0.00 0.00
γ1 0.50 0.49 0.06 0.38 0.59 61.00 0.00
γ1 0.50 0.49 0.06 0.37 0.58 0.00 0.00
γ2 1.30 1.30 0.04 1.24 1.37 1.00 0.00
γ2 1.30 1.30 0.04 1.23 1.38 0.00 0.00
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Table 3: Summary descriptive statistics of posterior means for the parameters of interest in the
100 simulations (GMCAR with covariates). BUGS (grey lines) and Rstan (white lines). Results
from running 4 chains, 6000 iterations for BUGS, 3000 for RStan and 50% warm-up for both.
%Rˆ > t indicates the percentage of Rˆ over threshold t in the 100 simulations
GMCAR-MM with Covariates
True mean sd 2.5% 97.5% %Rˆ > 1.01 %Rˆ > 1.1
α1 0.40 0.53 0.07 0.44 0.72 9.00 0.00
α1 0.40 0.50 0.04 0.44 0.58 1.00 0.00
α2 0.20 0.48 0.08 0.37 0.69 17.00 0.00
α2 0.20 0.44 0.07 0.36 0.63 1.00 0.00
τ1 6.00 5.19 0.73 3.74 6.55 86.00 1.00
τ1 6.00 5.63 0.66 4.20 6.83 0.00 0.00
τ2 4.00 5.80 1.19 3.24 7.39 95.00 5.00
τ2 4.00 6.24 1.37 3.09 8.48 0.00 0.00
η0 0.30 0.59 0.54 -0.32 1.61 99.00 42.00
η0 0.30 0.34 0.48 -0.55 1.19 3.00 0.00
η1 0.50 0.04 0.10 -0.16 0.19 98.00 7.00
η1 0.50 0.35 0.24 -0.18 0.75 5.00 0.00
ψ1 20.00 16.84 3.57 9.85 24.25 56.00 0.00
ψ1 20.00 18.52 3.33 12.02 24.04 0.00 0.00
ψ2 10.00 10.21 1.24 8.20 13.15 5.00 0.00
ψ2 10.00 9.85 1.21 7.44 12.15 0.00 0.00
γ1 -0.30 -0.34 0.22 -0.82 0.00 97.00 1.00
γ1 -0.30 -0.32 0.20 -0.69 0.03 1.00 0.00
γ2 -0.50 -0.50 0.10 -0.68 -0.34 85.00 1.00
γ2 -0.50 -0.50 0.09 -0.66 -0.33 1.00 0.00
β11 0.30 0.31 0.30 -0.23 0.87 85.00 0.00
β11 0.30 0.28 0.32 -0.29 0.87 0.00 0.00
β12 0.50 0.55 0.34 -0.00 1.27 100.00 2.00
β12 0.50 0.47 0.32 -0.01 1.07 0.00 0.00
β21 1.00 1.19 0.15 0.91 1.43 32.00 0.00
β21 1.00 1.20 0.13 0.94 1.43 1.00 0.00
β22 1.00 1.00 0.17 0.70 1.32 84.00 2.00
β22 1.00 0.99 0.15 0.70 1.30 0.00 0.00
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Table 4: Summary descriptive statistics of posterior means for the parameters of interest in the
100 simulations (MCAR with covariates). BUGS (grey lines) and Rstan (white lines). Results
from running 4 chains, 6000 iterations for BUGS, 3000 for RStan and 50% warm-up for both.
%Rˆ > t indicates the percentage of Rˆ over threshold t in the 100 simulations
MCAR-MM with Covariates
True mean sd 2.5% 97.5% %Rˆ > 1.01 %Rˆ > 1.1
α 0.40 0.45 0.07 0.34 0.61 16.00 0.00
α 0.40 0.43 0.06 0.35 0.57 0.00 0.00
τ1 6.00 5.82 0.71 4.58 7.06 88.00 0.00
τ1 6.00 5.90 0.60 4.76 7.03 0.00 0.00
τ2 4.00 5.62 1.30 2.98 7.60 87.00 0.00
τ2 4.00 5.62 1.25 3.05 7.49 0.00 0.00
η0 0.30 0.18 0.43 -0.63 0.93 100.00 21.00
η0 0.30 0.12 0.39 -0.59 0.91 0.00 0.00
ψ1 20.00 19.22 3.78 12.43 25.91 22.00 0.00
ψ1 20.00 19.53 3.34 13.74 25.96 0.00 0.00
ψ2 10.00 10.15 1.43 7.75 13.06 2.00 0.00
ψ2 10.00 10.18 1.49 7.74 13.32 0.00 0.00
γ1 -0.30 -0.33 0.16 -0.65 -0.03 95.00 6.00
γ1 -0.30 -0.34 0.15 -0.63 -0.05 0.00 0.00
γ2 -0.50 -0.51 0.10 -0.70 -0.34 55.00 0.00
γ2 -0.50 -0.51 0.11 -0.69 -0.34 0.00 0.00
β11 0.30 0.29 0.23 -0.16 0.69 85.00 0.00
β11 0.30 0.31 0.23 -0.12 0.69 0.00 0.00
β12 0.50 0.49 0.29 -0.06 1.00 96.00 4.00
β12 0.50 0.51 0.26 0.05 0.97 0.00 0.00
β21 1.00 1.20 0.14 0.92 1.47 9.00 0.00
β21 1.00 1.21 0.13 0.96 1.48 0.00 0.00
β22 1.00 1.02 0.18 0.66 1.34 58.00 0.00
β22 1.00 1.01 0.18 0.72 1.34 0.00 0.00
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Table 5: Summary statistics for the estimated parameter for the four models on the real data
(‘-C’ stands for models with covariates). βj1: South Asian population coefficient, βj2: IMD
coefficient for outcome j = 1, 2. Results from 4 chains of 2500 iterations and 50% warm-up with
Rstan.
mean se mean sd 2.5% 5% 95% 97.5% Rhat
α1
GMCAR 0.43 0.01 0.27 0.02 0.04 0.90 0.94 1.00
GMCAR-C 0.43 0.01 0.27 0.02 0.03 0.90 0.95 1.00
α2
GMCAR 0.97 0.00 0.03 0.88 0.91 1.00 1.00 1.01
GMCAR-C 0.36 0.00 0.24 0.01 0.03 0.81 0.88 1.00
α
MCAR 0.96 0.00 0.04 0.86 0.89 1.00 1.00 1.01
MCAR-C 0.33 0.01 0.23 0.01 0.03 0.76 0.83 1.00
τ1
GMCAR 5.85 0.05 2.83 1.85 2.19 11.19 12.41 1.00
GMCAR-C 6.07 0.05 2.80 1.91 2.31 11.36 12.58 1.00
MCAR 6.94 0.06 2.91 2.44 2.94 12.24 13.73 1.00
MCAR-C 5.85 0.04 2.82 1.90 2.20 11.13 12.54 1.00
τ2
GMCAR 3.56 0.04 1.24 1.58 1.81 5.79 6.42 1.01
GMCAR-C 9.75 0.04 3.04 4.66 5.26 15.18 16.39 1.00
MCAR 3.35 0.05 1.22 1.51 1.69 5.59 6.19 1.00
MCAR-C 9.19 0.04 3.06 4.02 4.74 14.66 16.13 1.00
η0
GMCAR -0.14 0.02 0.48 -1.07 -0.92 0.68 0.82 1.01
GMCAR-C 0.24 0.04 1.09 -1.88 -1.56 1.99 2.31 1.00
MCAR 0.54 0.01 0.26 0.04 0.13 0.96 1.05 1.01
MCAR-C 0.31 0.02 0.90 -1.51 -1.22 1.71 2.00 1.00
η1
GMCAR 0.18 0.00 0.11 -0.04 -0.01 0.35 0.39 1.01
GMCAR-C 0.04 0.02 0.44 -0.82 -0.69 0.76 0.90 1.00
ψ1
GMCAR 20.43 0.16 11.30 6.57 7.57 42.21 49.32 1.00
GMCAR-C 20.60 0.14 11.22 6.71 7.82 42.51 49.92 1.00
MCAR 18.33 0.18 10.65 5.85 6.82 39.41 46.29 1.00
MCAR-C 19.87 0.16 11.17 6.37 7.33 41.04 48.01 1.00
ψ2
GMCAR 16.56 0.04 2.70 11.98 12.57 21.35 22.48 1.00
GMCAR-C 17.80 0.03 2.66 12.99 13.80 22.33 23.77 1.00
MCAR 16.69 0.05 2.65 12.03 12.68 21.29 22.40 1.00
MCAR-C 17.84 0.03 2.73 13.03 13.71 22.54 23.66 1.00
γ1
GMCAR 0.19 0.01 0.16 -0.09 -0.04 0.49 0.57 1.02
GMCAR-C -0.35 0.00 0.17 -0.70 -0.63 -0.07 -0.01 1.00
MCAR 0.12 0.01 0.20 -0.27 -0.19 0.46 0.57 1.01
MCAR-C -0.36 0.00 0.15 -0.67 -0.62 -0.12 -0.07 1.00
γ2
GMCAR 0.12 0.01 0.18 -0.23 -0.14 0.43 0.51 1.04
GMCAR-C -0.63 0.00 0.08 -0.78 -0.76 -0.50 -0.48 1.00
MCAR 0.00 0.02 0.19 -0.41 -0.32 0.31 0.41 1.02
MCAR-C -0.63 0.00 0.08 -0.79 -0.76 -0.50 -0.48 1.00
β11
GMCAR-C 0.51 0.00 0.23 0.04 0.12 0.90 0.96 1.00
MCAR-C 0.52 0.00 0.21 0.11 0.17 0.87 0.93 1.00
β12
GMCAR-C 0.65 0.00 0.29 0.09 0.18 1.12 1.20 1.00
MCAR-C 0.67 0.00 0.27 0.15 0.24 1.10 1.19 1.00
β21
GMCAR-C 0.86 0.00 0.10 0.67 0.70 1.02 1.05 1.00
MCAR-C 0.86 0.00 0.10 0.66 0.70 1.02 1.06 1.00
β22
GMCAR-C 0.83 0.00 0.13 0.57 0.61 1.04 1.07 1.00
MCAR-C 0.82 0.00 0.13 0.57 0.61 1.04 1.08 1.00
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Table 6: Pearson correlation between areal relative risks (ρ and ζ)) at each iteration of the
HMC on the ONEL data (4 chains of 2500 iterations and 50% warm-up with Rstan).
mean se mean sd 2.5% 5% 95% 97.5% Rhat
GMCAR 0.43 0.01 0.25 -0.07 -0.01 0.81 0.85 1
GMCAR-C 0.61 0.00 0.18 0.19 0.26 0.85 0.87 1
MCAR 0.70 0.00 0.16 0.30 0.39 0.90 0.92 1
MCAR-C 0.65 0.00 0.17 0.25 0.33 0.87 0.89 1
Table 7: Fit measures summary for all four models for Mortality (95 areas)
D(θ¯) D(θ) pD DIC looic Mean(TAP)
GMCAR 78.12 94.64 16.52 111.16 412.9 0.63
GMCAR (covariates) 74.68 93.78 19.09 112.87 413.7 0.63
MCAR 83.40 98.15 14.75 112.9 418.0 0.56
MCAR (covariates) 78.91 95.17 16.26 111.43 412.6 0.62
Table 8: Fit measures summary for all four models for Prevalence (130 GP practices)
D(θ¯) D(θ) pD DIC looic Mean(TAP)
GMCAR 121.30 141.14 19.84 160.98 1524.2 0.33
GMCAR (covariates) 131.62 142.45 10.83 153.28 1513.0 0.32
MCAR 121.23 141.46 20.23 161.69 1523.6 0.33
MCAR (covariates) 131.12 142.34 11.22 153.56 1509.9 0.31
Table 9: Comparison of the mean and standard error of the elpd differences: êlpd
A
loo − êlpd
B
loo.
Positive value indicates better predictive performance for model A, negative values indicate
better performance for model B (‘-C’ stands for models with covariates).
Mortality
Model A Model B Mean se
GMCAR MCAR 2.5 1.2
GMCAR-C MCAR-C -0.6 0.4
GMCAR GMCAR-C 0.4 1.5
MCAR MCAR-C -2.3 1.3
Prevalence
Model A Model B Mean se
GMCAR MCAR -0.3 0.6
GMCAR-C MCAR-C -2.5 1.7
GMCAR GMCAR-C -5.6 4.3
MCAR MCAR-C -8.4 2.5
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Table 10: Proportion of tail area probabilities in different intervals for the four models and both
outcomes (‘-C’ stands for models with covariates).
Mortality Prevalence
[0, 0.05] ∪ [0.95, 1] [0, 0.1] ∪ [0.90, 1] [0, 0.05] ∪ [0.95, 1] [0, 0.1] ∪ [0.90, 1]
GMCAR 0.042 0.08 0.015 0.023
GMCAR-C 0.032 0.074 0.015 0.023
MCAR 0.042 0.084 0.015 0.015
MCAR-C 0.042 0.074 0.015 0.023
close to the number of observations, suggesting a good fit of the model to the data. We compared
LOO for GMCAR-MM and MCAR-MM models using differences in elpd as described in Section
3.3. This shows that the GMCAR-MM mortality model is preferable to the MCAR-MM one,
showing a difference of 2.5 (on the elpd scale) and a standard error of 1.2. Also, the addition
of covariates shows a significant improvement for the MCAR-MM prevalence model with an
average elpd difference of 8.4 (standard error 2.5). Other model comparisons in Table 9 do not
show significant differences in leave-one-out cross validation prediction.
Table 7 and 8 show that the estimated posterior mean values of TAP never exceed 0.63
and are never below 0.31, as expected with adequately fitting models. Additionally, in Table
10 we can clearly see that it is very unlikely for the replicated values across all models to be
sampled systematically over or under the dataset values. Figures 2 and 3 display densities for
the replicated data at each iteration with the actual data.
All models fit the data adequately, but there are important differences in the results when
covariates are included in the models. Consider the bridging parameters η0 and η1. The former
accounts for within area correlation between spatial effects for different outcomes, and the latter
represents between area association (i.e a form of spatial lag effect). Only η0 for the MCAR
without covariates shows an entirely positive 95% credible interval (0.04, 1.05). The results
in Table 9 show a strong within area association between the two outcomes. For the GMCAR
models, η1 for the GMCAR without covariates is close to significance with a 90% credible interval
spanning between -0.01 and 0.35. So the association between outcomes remains positive but
shows up as via a neighbourhood feedback effect with regards to surrounding areas.
Posterior Pearson’s correlation between relative risks is shown in table 6. As expected the
two outcomes display a positive correlation that is increased by the addition of covariates to the
model in the case of the GMCAR, and slightly decreased, though remaining rather high, for the
MCAR.
Posterior samples for the coefficients β on the covariates, show a strong positive impact, as
expected, for both the proportion of South Asian population and the deprivation index IMD,
in accounting for both prevalence and mortality variations. Covariate effects are stronger on
prevalence variations. The inclusion of such covariates generally improves fit, the exception
being the GMCAR model for mortality.
With regards to measures of spatial dependence (the α parameters) these are considerably
affected by the presence or not of covariates, especially when adding covariates improves fit. For
prevalence, inclusion of covariates leads to reduced DIC and LOO-IC, and the α parameters are
correspondingly reduced; the covariates account for spatial dependence formerly in the residuals.
For mortality, impacts of covariates are significant (albeit smaller than those for prevalence) but
fit is not improved when they are included.
With regards to the clustering analysis, Figures 6 and 7 show the areas belonging to the four
risk cluster categories. When an area (MSOA) is drawn in black, it means that it belongs to the
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Figure 2: Densities for mortality y and replicated data at each replication yrep
(a) (b)
(c) (d)
17
Figure 3: Densities for prevalence y and replicated data at each replication yrep
(a) (b)
(c) (d)
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Figure 4: Estimated mortality relative risks (posterior means of ρ1) for the area of interest
according to the four models.
(a)
(b)
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Figure 5: Estimated prevalence relative risks for the area of interest (posterior means of ζ2)
according to the four models.
(a)
(b)
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HH category and therefore it is surrounded by other areas with a global average of high relative
risk, while being itself of high relative risk, therefore lying at the centre of a high risk cluster.
Most MSOAs tend to lie in the LL category (see also Tables 11 and 12), with the higher risk
ones (HH and HL) concentrated in the south west part of the map, namely areas adjacent to
inner London.
For mortality, as noted above the addition of covariates tends to decrease relative risk overall.
However, Figure 6 highlights two MSOAs of particular interest. Redbridge 002 (RB, E02000752)
and Barking and Dagenham 009 (BD, E02000010) move from low relative risk mortality in the
models without covariates to high relative risk for that same outcome, while prevalence maintains
the low risk profile across all models. Both areas have an high mortality count (RB: 7, BD:
6) but comparatively low expected counts (RB: 3.02, BD: 2.63) and both areas are bordering
mostly areas with few deaths. Consequently, in the intercept-only models, relative risks for
those areas were likely shrunk toward the lower neighbourhood values, while the addition of
covariates allows the model to discriminate these areas, and highlight their higher risk.
Additional covariates would help shedding more light on the reason why areas in Redbridge
and Barking and Dagenham CCGs report such a high number of deaths by diabetes.
Similarly, in the case of prevalence (Figure 7) Barking and Dagenham 001 and 014 (E02000002
and E02000015) are classified as high risk only when covariates are included. While both areas
have a relatively low share of South Asian residents (8.78 and 3.44 %, global mean of 15.67 %),
they are respectively the 8th and 1st most deprived MSOAs in the ONEL area (IMD of 38.5 and
43.2, global mean of 22.56). This explains how the inclusion of covariates augments the relative
risk, since the effect of deprivation is estimated globally on the ONEL area.
Figure 8 also highlights those same areas just mentioned, by displaying the maps of bivariate
risk clustering.
Table 11: Number of areas belonging to the four clustering categories, arising from comparing an
area’s probability of high relative risk (PH(i, 1), Eq. 21) to its locality probability (PH(∼ i, 1),
Eq. 22) for mortality from the four models
GMCAR-MM
H PH(∼ i, 1) L PH(∼ i, 1)
H PH(i, 1) 18 1
L PH(i, 1) 23 53
GMCAR-MM with Covariates
H PH(∼ i, 1) L PH(∼ i, 1)
H PH(i, 1) 9 3
L PH(i, 1) 30 53
MCAR-MM
H PH(∼ i, 1) L PH(∼ i, 1)
H PH(i, 1) 16 0
L PH(i, 1) 25 54
MCAR-MM with Covariates
H PH(∼ i, 1) L PH(∼ i, 1)
H PH(i, 1) 19 1
L PH(i, 1) 23 52
When instead we move to bivariate clustering, we can see in Table 13 that under all four
models most of the within area risk categories tend to agree, i.e. they tend to lie in the top
left corner cells (between 7% and 15% M:H-P:H) and bottom right (between 75% and 87 %
M:L-P:L). This shows that almost all high (low) risk areas for prevalence are also high (low)
risk areas for mortality. We note that this holds true for the MCAR-MM model as well, which
unlike the GMCAR-MM model, does not assume causal precedence.
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Table 12: Number of areas belonging to the four clustering categories, arising from comparing an
area’s probability of high relative risk (PH(i, 1), Eq. 21) to its locality probability (PH(∼ i, 1),
Eq. 22) for prevalence from the four models
GMCAR-MM
H PH(∼ i, 1) L PH(∼ i, 1)
H PH(i, 1) 23 0
L PH(i, 1) 13 59
GMCAR-MM with Covariates
H PH(∼ i, 1) L PH(∼ i, 1)
H PH(i, 1) 25 2
L PH(i, 1) 13 55
MCAR-MM
H PH(∼ i, 1) L PH(∼ i, 1)
H PH(i, 1) 21 0
L PH(i, 1) 13 61
MCAR-MM with Covariates
H PH(∼ i, 1) L PH(∼ i, 1)
H PH(i, 1) 25 2
L PH(i, 1) 14 54
Table 13: Number of areas classified according to bivariate within area risk categories (Section
3.2) for the four models (TR = 1 see Eq. 20 and TP = 0.9)
GMCAR-MM
Prevalence
H-H H-L L-H L-L
M
o
rt
a
li
ty H-H 15 0 3 0
H-L 0 0 0 1
L-H 8 0 9 6
L-L 0 0 1 52
GMCAR-MM with Covariates
Prevalence
H-H H-L L-H L-L
M
o
rt
a
li
ty H-H 8 0 1 0
H-L 1 0 0 2
L-H 15 1 10 4
L-L 1 1 2 49
MCAR-MM
Prevalence
H-H H-L L-H L-L
M
o
rt
a
li
ty H-H 15 0 0 1
H-L 0 0 0 0
L-H 6 0 12 7
L-L 0 0 1 53
MCAR-MM with Covariates
Prevalence
H-H H-L L-H L-L
M
o
rt
a
li
ty H-H 8 0 7 4
H-L 0 0 0 1
L-H 0 0 15 8
L-L 0 0 1 51
6 Conclusions
No previous studies have investigated the bivariate spatial relationship between diabetes mor-
tality and prevalence for small areas. Evidence on the small area patterning of diabetes has
gained increased importance as diabetes is a recognized risk factor for Covid-19 (Guo et al.,
2020).
Although recording of diabetes deaths data can be problematic, with possible undercounting,
the models we propose show strong impacts of acknowledged area risk factors (area deprivation
and ethnic population mix) on both outcomes. In models not including covariates, spatial asso-
ciation and dependence parameters are mostly in line with broader epidemiological knowledge:
e.g. a positive association between the two outcomes. Analysis of posterior relative risks shows
clear clustering of high risk in a relatively few areas in the western part of the region studied,
while low risk (and low-low clusters) characterise a higher number of areas.
The analysis is complicated by the fact that prevalence is not observed directly for areas
22
but for a different set of spatial units: general practitioner catchment areas. We have used a
form of multiple membership principle to transfer information between these spatial frameworks.
Posterior checks confirm that this approach is successful.
To the best of our knowledge, so far RStan has been limited to univariate CAR models.
The approach we have used extends use of RStan to a bivariate CAR application, and can be
extended to more than two outcomes using the conditionality principle.
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Figure 6: Mapping of areal risk categories (Section 3.2) for mortality and the four models
(TR = 1 see Eq. 20 and TP = 0.9)
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Figure 7: Mapping of areal risk categories (Section 3.2) for prevalence and the four models
(TR = 1 see Eq. 20 and TP = 0.9)
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Figure 8: Mapping of bivariate within area risk categories (Section 3.2) for the four models
(TR = 1 see Eq. 20 and TP = 0.9)
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